Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Dahele

Showing results (61-70 of 162) with videos related to

Pageof 17
Sort By:
Acta Oncologica (Stockholm, Sweden)|October 27, 2012
Tumor size does not predict pathological complete response rates after pre-operative chemoradiotherapy for non-small cell lung cancerCornelis G Vos, Max Dahele, Chris Dickhoff, et al.
Medical Physics|May 25, 2024
Technical note: Dosimetry and FLASH potential of UHDR proton PBS for small lung tumors: Bragg-peak-based delivery versus transmission beam and IMPTPatricia van Marlen, Steven van de Water, Ben J Slotman, et al.
Medical Physics|February 11, 2014
Toward optimal organ at risk sparing in complex volumetric modulated arc therapy: an exponential trade-off with target volume dose homogeneityJim P Tol, Max Dahele, Patricia Doornaert, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 2, 2019
Systematic review of educational interventions to improve contouring in radiotherapyJon Cacicedo, Arturo Navarro-Martin, Susana Gonzalez-Larragan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 28, 2013
Frameless high dose rate stereotactic lung radiotherapy: intrafraction tumor position and delivery timeNicolas Peguret, Max Dahele, Johan P Cuijpers, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 3, 2014
Different treatment planning protocols can lead to large differences in organ at risk sparingJim P Tol, Max Dahele, Patricia Doornaert, et al.
International Journal of Radiation Oncology, Biology, Physics|January 15, 2015
Stereotactic ablative radiation therapy for subcentimeter lung tumors: clinical, dosimetric, and image guidance considerationsAlexander V Louie, Suresh Senan, Max Dahele, et al.
Acta Oncologica (Stockholm, Sweden)|December 19, 2014
Use of diffusion-weighted magnetic resonance imaging (DW-MRI) to investigate the effect of chemoradiotherapy on the salivary glandsPatricia Doornaert, Max Dahele, Redina Ljumanovic, et al.
Advances in Radiation Oncology|June 11, 2021
Markerless Real-Time 3-Dimensional kV Tracking of Lung Tumors During Free Breathing Stereotactic Radiation TherapyKimmie de Bruin, Max Dahele, Hassan Mostafavi, et al.
Cureus|February 22, 2019
Evaluation of an Automated Proton Planning SolutionAlexander R Delaney, Wilko F Verbakel, Jari Lindberg, et al.
Pageof 17

Showing results (61-70 of 162) with videos related to

Sort By:
Pageof 17
Acta Oncologica (Stockholm, Sweden)|October 27, 2012
Tumor size does not predict pathological complete response rates after pre-operative chemoradiotherapy for non-small cell lung cancerCornelis G Vos, Max Dahele, Chris Dickhoff, et al.
Medical Physics|May 25, 2024
Technical note: Dosimetry and FLASH potential of UHDR proton PBS for small lung tumors: Bragg-peak-based delivery versus transmission beam and IMPTPatricia van Marlen, Steven van de Water, Ben J Slotman, et al.
Medical Physics|February 11, 2014
Toward optimal organ at risk sparing in complex volumetric modulated arc therapy: an exponential trade-off with target volume dose homogeneityJim P Tol, Max Dahele, Patricia Doornaert, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 2, 2019
Systematic review of educational interventions to improve contouring in radiotherapyJon Cacicedo, Arturo Navarro-Martin, Susana Gonzalez-Larragan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 28, 2013
Frameless high dose rate stereotactic lung radiotherapy: intrafraction tumor position and delivery timeNicolas Peguret, Max Dahele, Johan P Cuijpers, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 3, 2014
Different treatment planning protocols can lead to large differences in organ at risk sparingJim P Tol, Max Dahele, Patricia Doornaert, et al.
International Journal of Radiation Oncology, Biology, Physics|January 15, 2015
Stereotactic ablative radiation therapy for subcentimeter lung tumors: clinical, dosimetric, and image guidance considerationsAlexander V Louie, Suresh Senan, Max Dahele, et al.
Acta Oncologica (Stockholm, Sweden)|December 19, 2014
Use of diffusion-weighted magnetic resonance imaging (DW-MRI) to investigate the effect of chemoradiotherapy on the salivary glandsPatricia Doornaert, Max Dahele, Redina Ljumanovic, et al.
Advances in Radiation Oncology|June 11, 2021
Markerless Real-Time 3-Dimensional kV Tracking of Lung Tumors During Free Breathing Stereotactic Radiation TherapyKimmie de Bruin, Max Dahele, Hassan Mostafavi, et al.
Cureus|February 22, 2019
Evaluation of an Automated Proton Planning SolutionAlexander R Delaney, Wilko F Verbakel, Jari Lindberg, et al.
Pageof 17